Massachusetts Financial Services’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,590,967
| Closed | -$5.73M | – | 884 |
|
|
2019
Q1 | $5.73M | Buy |
1,590,967
+91,800
| +6% | +$330K | ﹤0.01% | 656 |
|
|
2018
Q4 | $9.19M | Buy |
1,499,167
+7,971
| +0.5% | +$48.9K | ﹤0.01% | 609 |
|
|
2018
Q3 | $8.71M | Buy |
1,491,196
+114,998
| +8% | +$672K | ﹤0.01% | 643 |
|
|
2018
Q2 | $5.85M | Buy |
1,376,198
+365,750
| +36% | +$1.55M | ﹤0.01% | 669 |
|
|
2018
Q1 | $4.46M | Buy |
1,010,448
+10,404
| +1% | +$45.9K | ﹤0.01% | 672 |
|
|
2017
Q4 | $5.26M | Buy |
1,000,044
+9,341
| +0.9% | +$49.1K | ﹤0.01% | 660 |
|
|
2017
Q3 | $6.07M | Buy |
990,703
+6,009
| +0.6% | +$36.8K | ﹤0.01% | 653 |
|
|
2017
Q2 | $7.12M | Sell |
984,694
-205
| -0% | -$1.48K | ﹤0.01% | 645 |
|
|
2017
Q1 | $5.22M | Sell |
984,899
-1,429
| -0.1% | -$7.57K | ﹤0.01% | 647 |
|
|
2016
Q4 | $7.08M | Sell |
986,328
-2,444
| -0.2% | -$17.5K | ﹤0.01% | 630 |
|
|
2016
Q3 | $9.26M | Buy |
988,772
+16,837
| +2% | +$158K | ﹤0.01% | 587 |
|
|
2016
Q2 | $6.14M | Buy |
971,935
+47,102
| +5% | +$298K | ﹤0.01% | 619 |
|
|
2016
Q1 | $5.11M | Buy |
924,833
+11,705
| +1% | +$64.6K | ﹤0.01% | 639 |
|
|
2015
Q4 | $5.1M | Sell |
913,128
-6,495
| -0.7% | -$36.2K | ﹤0.01% | 650 |
|
|
2015
Q3 | $7.78M | Sell |
919,623
-60,864
| -6% | -$515K | ﹤0.01% | 622 |
|
|
2015
Q2 | $14.8M | Sell |
980,487
-14,562
| -1% | -$220K | 0.01% | 567 |
|
|
2015
Q1 | $15.9M | Sell |
995,049
-115,263
| -10% | -$1.85M | 0.01% | 569 |
|
|
2014
Q4 | $19.8M | Sell |
1,110,312
-136,091
| -11% | -$2.43M | 0.01% | 529 |
|
|
2014
Q3 | $12.5M | Buy |
1,246,403
+268,284
| +27% | +$2.69M | 0.01% | 609 |
|
|
2014
Q2 | $15.3M | Buy |
978,119
+149,919
| +18% | +$2.34M | 0.01% | 576 |
|
|
2014
Q1 | $15.4M | Buy |
+828,200
| New | +$15.4M | 0.01% | 537 |
|